Review of Bleeding and Thrombotic Risks Associated With Antithrombotic Therapy After Transcatheter Structural Heart Interventions.

15 Notably, there is a decreasing trend in the incidence rates of both bleeding and thrombotic events as the clinical indication of TAVR shifts from high risk to intermediate or low risk.

also in 47,180 other papers